Abstract
Randomized patient clinical trials are widely accepted as the standard for evaluation of therapeutic innovation in many fields of medicine. The 3 basic components of such trials (concurrent comparison, random allocation and objective observation) are designed to control 4 forms of bias (chronology bias, susceptibility bias, compliance bias and observation bias) that may interfere with the interpretation of the results of a study. Only 2% of the articles evaluating therapeutic maneuvers published in the Journal of Neurosurgery have attempted to use concurrent controls. Only 1 of 863 such articles met the criteria for a randomized clinical trial. Reasons for underutilization of such trials in neurosurgery are discussed and suggestions for their wider use are offered.